News
Tiziana Life Sci PLC - Grant of Options - Director Dealing
London, 1 May 2018- Tiziana Life Sciences plc, the clinical stage biotechnology company focused on targeted drugs to treat diseases in oncology and immunology, announces that the remuneration committee proposed and the board of directors of the Company has awarded the following options on 1 May 2018.. The options are exercisable at a price of 81.75 pence per...
London, 1 May 2018- Tiziana Life Sciences plc, the clinical stage biotechnology company focused on targeted drugs to treat diseases in oncology and immunology, announces that the remuneration committee proposed and the board of directors of the Company has awarded the following options on 1 May 2018.. The options are exercisable at a price of 81.75 pence per...